These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36166724)

  • 1. Real-World Cost of Pediatric Acute Lymphoblastic Leukemia Care Among Commercially Insured Individuals in the United States: Effect of Era and Age at Diagnosis.
    Turcotte LM; Watson D; Tanner L; Hoover A; Gilchrist L; Finch M; Messinger YH
    JCO Oncol Pract; 2022 Nov; 18(11):e1750-e1761. PubMed ID: 36166724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL.
    Hoover A; Watson D; Reimche P; Tanner L; Gilchrist L; Finch M; Messinger YH; Turcotte LM
    BMC Res Notes; 2024 Apr; 17(1):112. PubMed ID: 38644484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis.
    Hoover A; Reimche P; Watson D; Tanner L; Gilchrist L; Finch M; Messinger YH; Turcotte LM
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1980. PubMed ID: 38217445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and Cost of Outpatient Rehabilitation Services for Pediatric Patients Treated for Acute Lymphoblastic Leukemia Using a Commercial Claims Database.
    Gilchrist L; Tanner L; Finch M; Watson D; Hoover A; Turcotte L; Messinger Y
    Arch Phys Med Rehabil; 2023 Nov; 104(11):1857-1864. PubMed ID: 37150426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ReCAP: Gaps in Insurance Coverage for Pediatric Patients With Acute Lymphoblastic Leukemia.
    Smits-Seemann RR; Kaul S; Hersh AO; Fluchel MN; Boucher KM; Kirchhoff AC; Smits-Seemann RR; Kaul S; Hersh AO; Fluchel MN; Boucher KM; Kirchhoff AC
    J Oncol Pract; 2016 Feb; 12(2):175-6; e207-14. PubMed ID: 26420890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Burden of Veno-occlusive Disease in Patients With B-cell Acute Lymphoblastic Leukemia in the United States.
    Zhang X; Song X; Lopez-Gonzalez L; Jariwala-Parikh K; Romanov V; Cong Z
    Clin Ther; 2018 Oct; 40(10):1711-1719.e1. PubMed ID: 30196935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expenditures among young adults with acute lymphoblastic leukemia by site of care.
    Wolfson JA; Bhatia S; Ginsberg J; Becker LK; Bernstein D; Henk HJ; Lyman GH; Nathan PC; Puccetti D; Wilkes JJ; Winestone LE; Kenzik KM
    Cancer; 2021 Jun; 127(11):1901-1911. PubMed ID: 33465248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia.
    Kaul S; Korgenski EK; Ying J; Ng CF; Smits-Seemann RR; Nelson RE; Andrews S; Raetz E; Fluchel M; Lemons R; Kirchhoff AC
    Cancer Med; 2016 Feb; 5(2):221-9. PubMed ID: 26714675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Tisagenlecleucel vs Standard Care in High-risk Relapsed Pediatric Acute Lymphoblastic Leukemia in Canada.
    Furzer J; Gupta S; Nathan PC; Schechter T; Pole JD; Krueger J; Pechlivanoglou P
    JAMA Oncol; 2020 Mar; 6(3):393-401. PubMed ID: 31971547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
    Berry EA; Heaton PT; Kelton CM
    J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Early Mortality in Young Adult Patients With Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California.
    Alvarez EM; Malogolowkin M; Li Q; Brunson A; Pollock BH; Muffly L; Wun T; Keegan THM
    J Oncol Pract; 2019 Apr; 15(4):e316-e327. PubMed ID: 30849003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization rate and costs in acute lymphoblastic leukemia of childhood in a low-income group: Financial impact in Northeast Mexico.
    Jaime-Pérez JC; Fernández LT; Jiménez-Castillo RA; Colunga-Pedraza JE; Padilla-Medina JR; Mancías-Guerra C; Gómez-Almaguer D
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Therapy Utilization Among Hospitalized Patients With Pediatric Acute Lymphoblastic Leukemia.
    Rodwin RL; Ma X; Ness KK; Kadan-Lottick NS; Wang R
    JCO Oncol Pract; 2022 Jul; 18(7):e1060-e1068. PubMed ID: 35427182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Ness KK; Bhatia S; Gurney JG
    JAMA; 2003 Oct; 290(15):2008-14. PubMed ID: 14559954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoblastic leukemia: A population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017.
    Sasaki K; Jabbour E; Short NJ; Jain N; Ravandi F; Pui CH; Kantarjian H
    Am J Hematol; 2021 Jun; 96(6):650-658. PubMed ID: 33709456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden.
    Katz AJ; Chia VM; Schoonen WM; Kelsh MA
    Cancer Causes Control; 2015 Nov; 26(11):1627-42. PubMed ID: 26376890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
    Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
    Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Care Costs for Patients with Heart Failure Escalate Nearly 3-Fold in Final Months of Life.
    Obi EN; Swindle JP; Turner SJ; Russo PA; Altan A
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1446-1456. PubMed ID: 27882835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.